🔗 Permalink

Inventor profile of:

Cornelius Pompe

City:

Munich

Country:

Germany

Published Applications:

Last publication date:

2025-12-04

Top Assignees for applications by Cornelius Pompe

The entities that hold a legal rights for patent applications filed by inventor Pompe Cornelius:

AMGEN RESEARCH (MUNICH) GMBH 7 Munich, Germany
Amgen Inc. 4 Thousand Oaks, CA United States
LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES 2 Les Ulis, France
LFB BIOTECHNOLOGIES 1 Les Ulis, France
Laboratorie Francais du Fractionnement et des Biotechnologies 1 Les Ulis, France
SCIL TECHNOLOGY GMBH 1 Martinsried, Germany

Recent patent applications by Pompe Cornelius

Cornelius Pompe from Munich, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-12-04

US20250368737A1

Chemistry; metallurgy

LOW PH PHARMACEUTICAL COMPOSITION COMPRISING T CELL ENGAGING ANTIBODY CONSTRUCTS

#2 | 2025-10-30

US20250333537A1

Chemistry; metallurgy

PSMA AND CD3 BISPECIFIC T CELL ENGAGING ANTIBODY CONSTRUCTS

#3 | 2025-05-22

US20250163177A1

Chemistry; metallurgy

BISPECIFIC T CELL ENGAGING ANTIBODY CONSTRUCTS

#4 | 2023-06-22

US20230192884A1

Chemistry; metallurgy

BISPECIFIC T CELL ENGAGING ANTIBODY CONSTRUCTS

#5 | 2023-04-06

US20230103401A1

Human necessities

PHARMACEUTICAL COMPOSITION COMPRISING BISPECIFIC ANTIBODY CONSTRUCTS

#6 | 2022-11-17

US20220362104A1

Human necessities

SYSTEMS AND APPROACHES FOR DRUG DELIVERY

#7 | 2021-03-11

US20210070878A1

Chemistry; metallurgy

PSMA and CD3 Bispecific T Cell Engaging Antibody Constructs

#8 | 2020-10-22

US20200332000A1

Chemistry; metallurgy

LOW PH PHARMACEUTICAL COMPOSITION COMPRISING T CELL ENGAGING ANTIBODY CONSTRUCTS

#9 | 2020-02-13

US20200048357A1

Chemistry; metallurgy

BCMA and CD3 bispecific T cell engaging antibody constructs

#10 | 2017-08-03

US20170218079A1

Chemistry; metallurgy

PSMA and CD3 bispecific T cell engaging antibody constructs

#11 | 2017-08-03

US20170218078A1

Chemistry; metallurgy

Bispecific T cell engaging antibody constructs

#12 | 2017-08-03

US20170218077A1

Chemistry; metallurgy

BCMA and CD3 bispecific T cell engaging antibody constructs

#13 | 2017-07-27

US20170209571A1

Human necessities

Pharmaceutical composition comprising bispecific antibody constructs

#14 | 2016-09-22

US20160271233A1

Human necessities

Factor VII composition

#15 | 2015-08-06

US20150216951A1

Human necessities

Factor VII composition

#16 | 2012-04-12

US20120087908A1

Human necessities

Factor VII composition

#17 | 2009-08-20

US20090209660A1

Chemistry; metallurgy

Biomaterial containing degradation stabilized polymer

InventorID:

1245701 ⎘